J&J accuses divisions of Cigna of helping drain its drug copay funds, WSJ reports

Johnson & Johnson Sues Cigna

(Reuters) – Johnson & Johnson (NYSE: JNJ) has initiated legal action against divisions of Cigna (NYSE: CI). The lawsuit accuses the health insurer of collaborating with a drug-benefit middleman to deplete J&J's financial-assistance funds designated for patients using some of its more expensive medications, as reported by The Wall Street Journal on Friday.